Comparison of Complications and Outcomes Following Transurethral Resection of the Prostate in Patients Presenting With and Without Acute Urinary Retention

TL;DR

This study compares outcomes of prostate surgery in patients with and without acute urinary retention, finding more complications in those with retention but no major differences in recovery.

Contribution

The study provides insights into TURP outcomes in patients with and without acute urinary retention, focusing on complication rates and recovery.

Findings

Patients with acute urinary retention had higher rates of postoperative complications like UTIs and hematuria.

Hospital stay duration and symptom resolution were similar between the AUR and non-AUR groups.

Differences in complication rates were not statistically significant.

Abstract

Objective: The objective of this study is to evaluate the outcomes and complications of transurethral resection of the prostate (TURP) in patients with and without acute urinary retention (AUR).

Methodology: This descriptive study was conducted in the Urology Department of the Institute of Kidney Diseases (IKD), Hayatabad Medical Complex (HMC), Peshawar, from 11th August 2023 to 11th February 2024. A total of 127 male patients aged over 40 years with prostate sizes between 40 and 80 grams on ultrasonography were included. Patients with a history of prostate cancer or prior prostate surgery were excluded. All participants underwent TURP, and postoperative complications, such as urinary tract infections (UTIs), hematuria, lower urinary tract symptoms (LUTS), recatheterization, and hospital stay length, were documented. Statistical analysis was performed using IBM SPSS Statistics for Windows, Version 23 (Released 2015; IBM Corp., Armonk, New York, United States) to compare outcomes between the AUR and non-AUR groups.

Results: The study included 127 patients with a mean age of 64.92 ± 3.8 years. The incidence of AUR was 63(49.6%). Postoperative complications such as UTIs (p=0.39), hematuria (p value= 0.06), LUTS (p=0.27), recatheterization (0.52), and sepsis (0.20) were more common in the AUR group, though these differences were not statistically significant. The need for blood transfusions was also higher in the AUR group (P=0.09). Hospital stay duration and symptom resolution were comparable between the AUR and non-AUR groups.

Conclusion: AUR in benign prostatic hyperplasia patients was associated with more severe symptoms and an increased frequency of certain postoperative complications, including UTIs, hematuria, and the need for blood transfusions. However, most differences between the AUR and non-AUR groups were not statistically significant.

Figures